These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26724400)

  • 1. Use of computer simulations to test the concept of dose forgiveness in the era of extended-release (XR) drugs.
    Pellock JM; Brittain ST
    Epilepsy Behav; 2016 Feb; 55():21-3. PubMed ID: 26724400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.
    Brittain ST; Wheless JW
    Epilepsy Behav; 2015 Nov; 52(Pt A):31-6. PubMed ID: 26409125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing impact of real-world dosing irregularities with lamotrigine extended-release and immediate-release formulations by pharmacokinetic simulation.
    Chen C; Wright J; Gidal B; Messenheimer J
    Ther Drug Monit; 2013 Apr; 35(2):188-93. PubMed ID: 23503444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release formulations for the treatment of epilepsy.
    Bialer M
    CNS Drugs; 2007; 21(9):765-74. PubMed ID: 17696575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate.
    Gidal BE; Clark AM; Anders B; Gilliam F
    Epilepsy Res; 2017 Jan; 129():26-32. PubMed ID: 27883934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
    Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
    Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.
    Anderson GD; Saneto RP
    CNS Drugs; 2015 Aug; 29(8):669-81. PubMed ID: 26369919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions.
    Conner TM; Reed RC; Zhang T
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):389-408. PubMed ID: 30460522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of extended-release topiramate in patients with epilepsy: A two-year retention study.
    Lee H; Kim DW
    J Clin Pharm Ther; 2021 Oct; 46(5):1412-1417. PubMed ID: 34146432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily lamotrigine extended release for epilepsy management.
    Rheims S; Ryvlin P
    Expert Rev Neurother; 2009 Feb; 9(2):167-73. PubMed ID: 19210192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations.
    Leppik IE; Hovinga CA
    Epilepsia; 2013 Jan; 54(1):28-35. PubMed ID: 23190215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.
    Polepally AR; Remmel RP; Brundage RC; Leppik IE; Rarick JO; Ramsay RE; Birnbaum AK
    J Clin Pharmacol; 2015 Oct; 55(10):1101-8. PubMed ID: 25903807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.
    Lamba M; Wang R; Fletcher T; Alvey C; Kushner J; Stock TC
    J Clin Pharmacol; 2016 Nov; 56(11):1362-1371. PubMed ID: 26970526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR
    Faison S; Gomeni R; Mendes S; O'Neal W; Schwabe S; Nasser A
    Clin Pharmacol; 2020; 12():135-147. PubMed ID: 33061671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do the suffixes--XR, ER, Chrono, Chronosphere--really mean as it pertains to modified-release antiepileptic drugs?
    Reed RC; Meinhold J; Dutta S; Liu W; Qiu Y
    J Clin Pharm Ther; 2010 Aug; 35(4):373-83. PubMed ID: 20831540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.